Establishing an Animal Model to Investigate Depression with Coronary Heart Disease

0
0
0

Establishing an Animal Model to Investigate Depression with Coronary Heart Disease

If you or someone you know has struggled with depression or coronary heart disease (CHD), you might not realize how closely these two conditions are connected. Worldwide, millions of people live with both—and they face a double burden: higher risk of death, worse recovery, and more severe symptoms. But studying exactly how depression and CHD feed into each other is tough in humans. That’s where animal models come in—and a new study from China offers a promising way to mimic this comorbidity in rats.

Coronary heart disease (the leading cause of death globally) and depression (the most common mental health disorder) often occur together. Research shows depression raises long-term CHD risk, while CHD increases depression risk—and people with both have worse outcomes. To untangle this link, scientists need reliable animal models that show both conditions. Until now, most models focused on one or the other: chronic unpredictable mild stress (CUMS) for depression, or high-fat diets (HFD) for CHD. A team from Kunming Medical University set out to combine these methods and see if they could create a model that mirrors human comorbidity.

How the Model Was Built

The researchers worked with 24 Wistar rats, split into three groups:

  1. Normal control (NC): No stress, regular food.
  2. CUMS: Isolated in cages and exposed to unpredictable stressors (e.g., 24 hours of tilted cages, 3-minute swims in 5°C water, overnight fasting, or light-cycle inversions) for 8 weeks.
  3. CUMS + HFD: Same stress as the CUMS group, plus a high-fat diet (3% cholesterol, 10% lard, 5% sugar, and other additives) and a single vitamin D3 injection (to boost CHD-related changes).

After 8 weeks, the team measured:

  • Depression-like behavior: Open field test (activity level) and forced swimming test (helplessness).
  • CHD signs: Microscopic analysis of heart/vessel tissue (oil red O staining for fat, hematoxylin-eosin (HE) staining for damage) and blood lipid levels (triglycerides, total cholesterol).
  • Brain health: Expression of brain-derived neurotrophic factor (BDNF)—a protein that supports mood and nerve growth, often low in depression.

What the Researchers Found

The results confirmed the model worked:

  • Depression-like symptoms: Both CUMS and CUMS + HFD groups moved half as far in the open field test (1603 cm vs. 800–821 cm for controls) and stayed immobile 2.5 times longer in the forced swimming test (24 seconds vs. 9.7 seconds for controls). Their BDNF levels were 10–20% lower than controls—consistent with human depression.
  • CHD-related damage: Only the CUMS + HFD group showed signs of heart and vessel disease:
    • Vessels: Oil red O staining revealed fat buildup (focal fat deposition) and thickened artery walls (diffuse intimal thickening) in heart and brain vessels.
    • Heart muscle: HE staining showed swelling, rupture, and death of heart cells, plus inflammation—changes not seen in controls or the CUMS group.
    • Lipids: Their blood had 50% higher triglycerides (1.6 mmol/L vs. 1.1 mmol/L for controls) and 2–3 times higher total cholesterol (1.1 mmol/L vs. 0.4–0.5 mmol/L for controls).

What This Means for Future Research

By combining CUMS and HFD, the team created a rat model that mimics both depression and CHD—filling a critical gap in research. Unlike single-method models, this one lets scientists study how the two conditions interact: Does depression worsen CHD by increasing stress hormones? Does CHD trigger depression by reducing blood flow to the brain? And most importantly, can treatments target both at once?

The model isn’t perfect—more tests are needed to confirm it works in other rat strains or longer-term studies. But it’s a crucial first step toward better understanding (and treating) the millions living with comorbid depression and CHD.

The Study Behind the Model

This research was led by Chun-Xia Guo, Fei Zheng, Yi-Ran Feng, Yu-Dong Rao, Ying Zhang, Zong-Ren Ma, Yan-Fang Zeng, Hao Zhou, Kun-Rong Yang, Wei Ni, and Xue-Ya Zhang from the Department of Traditional Chinese Medicine at the First Affiliated Hospital of Kunming Medical University in Kunming, Yunnan, China. It was published in the Chinese Medical Journal in 2019 and funded by the National Natural Science Foundation of China (No. 81560730) and the Training Project for Young and Middle-aged Chinese Medicine Leaders in Yunnan Province.

doi.org/10.1097/CM9.0000000000000561

Was this helpful?

0 / 0